These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 20133699)
21. Genetic variation at the 8q24.21 renal cancer susceptibility locus affects HIF binding to a MYC enhancer. Grampp S; Platt JL; Lauer V; Salama R; Kranz F; Neumann VK; Wach S; Stöhr C; Hartmann A; Eckardt KU; Ratcliffe PJ; Mole DR; Schödel J Nat Commun; 2016 Oct; 7():13183. PubMed ID: 27774982 [TBL] [Abstract][Full Text] [Related]
22. Variant Max protein, derived by alternative splicing, associates with c-Myc in vivo and inhibits transactivation. Arsura M; Deshpande A; Hann SR; Sonenshein GE Mol Cell Biol; 1995 Dec; 15(12):6702-9. PubMed ID: 8524235 [TBL] [Abstract][Full Text] [Related]
23. Long-distance interaction of the integrated HPV fragment with MYC gene and 8q24.22 region upregulating the allele-specific MYC expression in HeLa cells. Shen C; Liu Y; Shi S; Zhang R; Zhang T; Xu Q; Zhu P; Chen X; Lu F Int J Cancer; 2017 Aug; 141(3):540-548. PubMed ID: 28470669 [TBL] [Abstract][Full Text] [Related]
24. In vivo transcriptional regulation of N-Myc target genes is controlled by E-box methylation. Perini G; Diolaiti D; Porro A; Della Valle G Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12117-22. PubMed ID: 16093321 [TBL] [Abstract][Full Text] [Related]
25. Down-regulation of Sox7 is associated with aberrant activation of Wnt/b-catenin signaling in endometrial cancer. Chan DW; Mak CS; Leung TH; Chan KK; Ngan HY Oncotarget; 2012 Dec; 3(12):1546-56. PubMed ID: 23295859 [TBL] [Abstract][Full Text] [Related]
26. Transcriptional activation by Myc is under negative control by the transcription factor AP-2. Gaubatz S; Imhof A; Dosch R; Werner O; Mitchell P; Buettner R; Eilers M EMBO J; 1995 Apr; 14(7):1508-19. PubMed ID: 7729426 [TBL] [Abstract][Full Text] [Related]
27. High β-catenin/Tcf-4 activity confers glioma progression via direct regulation of AKT2 gene expression. Zhang J; Huang K; Shi Z; Zou J; Wang Y; Jia Z; Zhang A; Han L; Yue X; Liu N; Jiang T; You Y; Pu P; Kang C Neuro Oncol; 2011 Jun; 13(6):600-9. PubMed ID: 21636708 [TBL] [Abstract][Full Text] [Related]
28. ETS variant transcription factor 5 and c-Myc cooperate in derepressing the human telomerase gene promoter via composite ETS/E-box motifs. Zhang F; Wang S; Zhu J J Biol Chem; 2020 Jul; 295(29):10062-10075. PubMed ID: 32518154 [TBL] [Abstract][Full Text] [Related]
29. Characterization of the colorectal cancer-associated enhancer MYC-335 at 8q24: the role of rs67491583. Tuupanen S; Yan J; Turunen M; Gylfe AE; Kaasinen E; Li L; Eng C; Culver DA; Kalady MF; Pennison MJ; Pasche B; Manne U; de la Chapelle A; Hampel H; Henderson BE; Marchand LL; Hautaniemi S; Askhtorab H; Smoot D; Sandler RS; Keku T; Kupfer SS; Ellis NA; Haiman CA; Taipale J; Aaltonen LA Cancer Genet; 2012; 205(1-2):25-33. PubMed ID: 22429595 [TBL] [Abstract][Full Text] [Related]
30. Myc cooperates with β-catenin to drive gene expression in nephron progenitor cells. Pan X; Karner CM; Carroll TJ Development; 2017 Nov; 144(22):4173-4182. PubMed ID: 28993399 [TBL] [Abstract][Full Text] [Related]
31. Human FasL gene is a target of β-catenin/T-cell factor pathway and complex FasL haplotypes alter promoter functions. Wu J; Richards MH; Huang J; Al-Harthi L; Xu X; Lin R; Xie F; Gibson AW; Edberg JC; Kimberly RP PLoS One; 2011; 6(10):e26143. PubMed ID: 22022540 [TBL] [Abstract][Full Text] [Related]
32. Chromatin dynamics at the hTERT promoter during transcriptional activation and repression by c-Myc and Mnt in Xenopus leavis oocytes. Wahlström T; Belikov S; Arsenian Henriksson M Exp Cell Res; 2013 Dec; 319(20):3160-9. PubMed ID: 23860446 [TBL] [Abstract][Full Text] [Related]
33. DEAD-box protein p68 is regulated by β-catenin/transcription factor 4 to maintain a positive feedback loop in control of breast cancer progression. Guturi KK; Sarkar M; Bhowmik A; Das N; Ghosh MK Breast Cancer Res; 2014 Dec; 16(6):496. PubMed ID: 25499975 [TBL] [Abstract][Full Text] [Related]
34. p73 Interacts with c-Myc to regulate Y-box-binding protein-1 expression. Uramoto H; Izumi H; Ise T; Tada M; Uchiumi T; Kuwano M; Yasumoto K; Funa K; Kohno K J Biol Chem; 2002 Aug; 277(35):31694-702. PubMed ID: 12080043 [TBL] [Abstract][Full Text] [Related]
35. Multiple androgen response elements and a Myc consensus site in the androgen receptor (AR) coding region are involved in androgen-mediated up-regulation of AR messenger RNA. Grad JM; Dai JL; Wu S; Burnstein KL Mol Endocrinol; 1999 Nov; 13(11):1896-911. PubMed ID: 10551783 [TBL] [Abstract][Full Text] [Related]
36. c-Myc is required for the CHREBP-dependent activation of glucose-responsive genes. Zhang P; Metukuri MR; Bindom SM; Prochownik EV; O'Doherty RM; Scott DK Mol Endocrinol; 2010 Jun; 24(6):1274-86. PubMed ID: 20382893 [TBL] [Abstract][Full Text] [Related]
37. Enhancement of Radiation Sensitivity in Lung Cancer Cells by a Novel Small Molecule Inhibitor That Targets the β-Catenin/Tcf4 Interaction. Zhang Q; Gao M; Luo G; Han X; Bao W; Cheng Y; Tian W; Yan M; Yang G; An J PLoS One; 2016; 11(3):e0152407. PubMed ID: 27014877 [TBL] [Abstract][Full Text] [Related]
38. β-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness. Sánchez-Tilló E; de Barrios O; Siles L; Cuatrecasas M; Castells A; Postigo A Proc Natl Acad Sci U S A; 2011 Nov; 108(48):19204-9. PubMed ID: 22080605 [TBL] [Abstract][Full Text] [Related]
39. ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors. Ciró M; Prosperini E; Quarto M; Grazini U; Walfridsson J; McBlane F; Nucifero P; Pacchiana G; Capra M; Christensen J; Helin K Cancer Res; 2009 Nov; 69(21):8491-8. PubMed ID: 19843847 [TBL] [Abstract][Full Text] [Related]